Cargando…
The association between adverse events and outcome under checkpoint inhibitors: Where is the deal?
Recent reports have put into evidence the possibility of a link between immune-related adverse events (IRAEs) and treatment outcome, patients drawing a benefit from treatment being also exposed to the risk to develop toxicity. A still unanswered question remains the biological origin(s) which can su...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708939/ https://www.ncbi.nlm.nih.gov/pubmed/33260071 http://dx.doi.org/10.1016/j.tranon.2020.100952 |